NEWS
View news from our Featured Companies.
Reviva Pharmaceuticals Announces Update on RECOVER, a Pivotal Phase 3 Global Study Evaluating Brilaroxazine for the Treatment of Schizophrenia
CUPERTINO, Calif., May 03, 2022 -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) ("Reviva" or the "Company"), a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS),...
Zoomd Reports Record Fourth Quarter and Fiscal 2021 Financial Results, with a record of $53M revenues. Expects Fiscal 2022 Revenues of $74M to $80M
Conference call will be held on Monday May 2nd at 11:00AM ET VANCOUVER, BC, May 2, 2022 /CNW/ -- Zoomd Technologies Ltd. (TSXV: ZOMD) (OTC: ZMDTF) and its wholly-owned subsidiary Zoomd Ltd. (collectively, "Zoomd" or the "Company"), the marketing technology (MarTech)...
IRADIMED CORPORATION Announces First Quarter 2022 Financial Results
Reports first quarter 2022 revenue of $12.3 million, GAAP diluted EPS of $0.20 and non-GAAP diluted EPS of $0.22Announces second quarter 2022 financial guidanceIncreases full-year 2022 financial guidance WINTER SPRINGS, Fla., April 29, 2022 -- IRADIMED CORPORATION...
ChromaDex to Report First Quarter 2022 Financial Results on Thursday, May 12, 2022
LOS ANGELES - ChromaDex Corp. (NASDAQ:CDXC) announced that it will hold a conference call on Thurs. May 12, 2022 at 4:30 p.m. ET to discuss its financial results for the first quarter, which ended March 31, 2022. The financial results will be reported in a press...
InfuSystem Announces Master Service Agreement with Leading Global Healthcare Technology and Diagnostic Company
Preferred National Service Agreement to provide service and repair to fleet of more than 300,000 pumps in North America; Estimated $10-$12 million of annual revenue ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU), ("InfuSystem" or the...
InfuSystem to Report First Quarter 2022 Financial Results on May 5, 2022
Investor Conference Call to be held 9:00 a.m. Eastern Time ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical...
IRADIMED CORPORATION Announces Executive Transition
WINTER SPRINGS, Fla., April 28, 2022 -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD), announced today announced that Chris Scott, Chief Financial and Operating Officer, has resigned from the Company effective May 27, 2022. Mr. Scott started at the Company in...
INVO Celebrates National Infertility Awareness Week at the INVO Center in Atlanta, Georgia
Bloom Fertility, an INVO Center to grant three eligible patients a full IVC treatment cycle SARASOTA, Fla., April 28, 2022 -- INVO Bioscience, Inc. (NASDAQ: INVO), a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with...
PolyPid to Report First Quarter 2022 Financial Results and Operational Highlights on May 11, 2022
PETACH TIKVA, Israel, April 27, 2022 -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it will report its first quarter 2022 financial results and operational...
Zoomd to Report 2021 Audited Financial Results on April 29, 2022
Conference call to be conducted on May 2, 2022 at 11 a.m. ET. VANCOUVER, BC, April 26, 2022 /CNW/ -- Zoomd Technologies Ltd. (TSXV: ZOMD) (OTC: ZMDTF) and its wholly-owned subsidiary Zoomd Ltd. (collectively, "Zoomd" or the "Company"), the marketing technology...
Reviva Pharmaceuticals to Host Key Opinion Leader Webinar on Brilaroxazine for Schizophrenia and Other Neuropsychiatric Disorders
Virtual event on Tuesday, May 3rd at 10:00 AM ET An overview of unmet medical needs and therapeutic opportunities in schizophrenia and major neuropsychiatric disorders will be discussed CUPERTINO, Calif., April 26, 2022 -- Reviva Pharmaceuticals Holdings, Inc....
Aytu BioPharma Announces Positive Preclinical Data in Ventilator-Associated Pneumonia with its Novel, Proprietary Healight™ Delivery Technology
Preclinical Proof-of-Concept Study Demonstrates Effectiveness of Healight in Delaying Time to Development of Ventilator-Associated PneumoniaENGLEWOOD, CO / April 25, 2022 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a pharmaceutical company focused on developing and...
PolyPid Announces Presentation at the 13th European and Global CLINAM Summit for Nanomedicine
Presentation evaluates the effect of D-PLEX100 in limiting occurrence of antimicrobial resistance (AMR) in colorectal surgery patients PETACH TIKVA, Israel, April 25, 2022 -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company...
Kiora Pharmaceuticals Announces Presentation of KIO-101 Clinical Trial Data at the American Society of Cataract and Refractive Surgery 2022
Results support planned Phase 2 Trial to treat the Ocular Presentation of Rheumatoid Arthritis (OPRA)Salt Lake City, Utah--(April 25, 2022) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), ("Kiora" or the "Company") announced that the full results of the KIO-101 Phase 1b...
ChromaDex Appoints Ann Cohen and Kristin Patrick to its Board of Directors
LOS ANGELES - ChromaDex Corp. (NASDAQ: CDXC) today announced that it has appointed two new members to its Board of Directors: Kristin Patrick, Executive Vice President and Chief Marketing Officer of Claire's Inc., and Ann Cohen, Executive Vice President and Chief...
Aytu BioPharma Announces Fast Track Designation Granted to AR101 for the Treatment of Vascular Ehlers-Danlos Syndrome
ENGLEWOOD, CO / April 19, 2022 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a pharmaceutical company focused on developing and commercializing novel therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to AR101...
Kiora Pharmaceuticals Reports 2021 Results and Provides Business Update
Salt Lake City, Utah--(April 15, 2022) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), ("Kiora" or the "Company") today reported its financial results for the quarter and year ended December 31, 2021 and provided an update on recent corporate and operational activities....
Jewett-Cameron Announces 2nd Quarter Financial Results
NORTH PLAINS, Ore., April 14, 2022 -- Jewett-Cameron Trading Company Ltd. (NASDAQ: JCTCF) today reported financial results for the second quarter and six month periods of fiscal 2022 ended February 28, 2022. Sales for the second quarter of fiscal 2022 totaled $14.06...
INVO Selects Kansas City as additional INVO Center Location
U.S. Market Expansion Continues as Planned SARASOTA, Fla., April 14, 2022 -- INVO Bioscience, Inc. (NASDAQ: INVO) ("INVO" or the "Company"), a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its INVOcell®...
ChromaDex External Research Program (CERP™) Celebrates Over 250 Research Agreements With 235+ Researchers Around the World
ChromaDex's research and development program reaches over 250 material transfer agreements (MTAs) on Niagen® and other ingredients, marking a milestone in NAD+ research LOS ANGELES - ChromaDex Corp. (NASDAQ:CDXC) today celebrates over 250 material transfer...
PolyPid Announces Presentation of Clinical Data at Surgical Infection Society 2022 Annual Meeting
Presentation evaluates the addition of D-PLEX to the surgical site infection standard of care prophylaxis regimen in elective colorectal surgeryPETACH TIKVA, Israel, April 12, 2022 -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a late-stage biopharma...
ImmuCell Announces Record Preliminary, Unaudited Sales Results for First Quarter of 2022
PORTLAND, Maine, April 11, 2022 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
PolyPid Secures $15 Million Non-Dilutive Secured Term Loan Facility
Secured Loan facility with Kreos Capital Extends Company's Cash Runway into the Second Quarter of 2023PETACH TIKVA, Israel, April 06, 2022 -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company aiming to improve surgical outcomes,...
ChromaDex Launches Tru Niagen® Immune, Further Expanding Innovative Product Portfolio
Tru Niagen® Immune is the first-ever immune health supplement with a targeted NAD+ boost for the optimal maintenance and function of aging cells LOS ANGELES - ChromaDex Corp. (NASDAQ:CDXC) today announced the company's latest product innovation with the U.S....
ARIANNE PHOSPHATE EXPANDS WORK ON ALTERNATIVE FERTILIZERS
-partners with Northern Nutrients of Canada to test direct applications DAN: TSX-V (CANADA) JE9N: FSE (GERMANY) RRSF: OTC (USA) SAGUENAY, QC, April 5, 2022 /CNW Telbec/ - Arianne Phosphate (the "Company" or "Arianne") (TSXV: DAN) (OTC: DRRSF) (FRANKFURT: JE9N), a...